期刊文献+

5-羟色胺综合征的临床特征、诊断及防治 被引量:9

Serotonin syndrome: clinical characteristics, diagnosis, treatment, and prevention
原文传递
导出
摘要 5-羟色胺综合征是一种由治疗药物引起的可能危及生命的不良反应。发生机制为5-羟色胺(5-HT)在神经系统内积蓄,过度激活突触后5-HT受体,导致5-HT能神经系统活动增强,其临床特征为精神障碍、自主神经功能亢进及神经肌肉功能异常。本综合征常发生于抗抑郁药联用或与其他药物联用时,主要依据临床表现诊断。治疗包括停撤可疑药物、密切观察、控制激越行为、给予5-HT拮抗剂、对症治疗、并发症的处理等。本综合征重在预防。 The serotonin syndrome is a potentially life-threatening adverse reactions that results from therapeutic drug use. The mechanisms are attributed to the increase on activity of serotonergic system because 5-hydroxytryptamine (5-HT) accumulates in nervous system and 5-HT postsynaptic receptors arc overactivated. The clinical feature is described as a clinical triad of mental-status changes, autonomic hyperactivity, and neuromuscular abnormalities. The syndrome often occurs in coadminstration among antidepressants or combination with other drugs. The diagnosis of the serotonin syndrome is mainly based on the clinical manifestation. Management of the serotonin syndrome involves the cessation of precipitating drugs, improvement of monitoring, control of agitation, administration of 5-HT antagonists, symptomatic treatment, the control of complication, etc. The prevention of the syndrome is more important than the treatment.
机构地区 解放军第
出处 《药物不良反应杂志》 2007年第3期195-200,共6页 Adverse Drug Reactions Journal
关键词 5-羟色胺综合征 发病机制 诊断 治疗 预防 serotonin syndrome mechanism diagnosis treatment prevention
  • 相关文献

参考文献26

  • 1Mason J, Freemantle N, Eccles M. Fatal toxicity associated with antidepressants use in primary care [J]. Br J Gen Pract, 2000, 50(454):360-370.
  • 2张小澍,鱼爱和.药源性神经系统疾病(三)[J].药物不良反应杂志,2005,7(5):363-367. 被引量:6
  • 3方媛,刘鸣,张世洪.5-羟色胺综合征的发病机制、诊断和治疗[J].中华神经科杂志,2006,39(4):278-280. 被引量:14
  • 4Boyer EW, Shannon M. The Serotonin Syndrome[J]. N Engl J Med, 2005, 352 (11):1112-1120.
  • 5Kanayama M, Hashimoto T, Shigenobu K, et al. New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial[J]. J Neurosurg Spine, 2005, 2(4):441-446.
  • 6Lo tsch J, Skarke C, Schneider A, et al. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression[J]. Clin Pharmacol Ther, 2005, 78(3):278-287.
  • 7Babaoglu MO, Bayar B, Aynacioglu AS, et al. Association of the ABCB1 3435C T polymorphism with antiemetic etticacy of 5-hydroxytryptamine type 3 antagonists[J]. Clin Pharmacol Ther, 2005, 78(6):619-626.
  • 8Horiuchi J, Wakabayashi S, Dampney RA. Activation of 5-Hydroxytryptamine 1A receptors suppresses the cardiovascular response evoked from the dorsomedial hypothalamic nucleus[J]. Hypertension, 2005, 46(1): 173-179.
  • 9Palea S, Lluel P, Barras M, et al. Involvement of 5-hydroxytryptamine(HT) 7 receptors in the 5-HT excitatory effects on the rat urinary bladder[J]. BJU Int, 2004, 94 (7): 1125-1131.
  • 10Siddiqui E J, Shabbir M, Mikhailidis DP, et al. The role of serotonin (5-hydroxytryptaminelA and 1B) receptors in prostate cancer cell proliferation[J]. J Urol, 2006, 176 (4 Pt 1):1648-1653.

二级参考文献24

  • 1Ellenhorn MJ. Ellenhorn's Medical Toxicology[M]. 2nd ed. Baltimore:Williams & Wilkins, 1997: 615-650; 903-904.
  • 2Dart R C. The 5 minute toxicology consult[M]. NewYork:Lippincott Williams & Wilkins, 2001: 54-55.
  • 3Hamilton S, Malone K. Serotonin Syndrome during treatment with paroxetine and risperidone[J]. J Clin Psycopharmacol, 2000, 20(1): 103.
  • 4智睿 丁玉江.血管紧张素转换酶抑制剂致血清素综合征1例[J].临床心血管病杂志,1999,15(7):305-305.
  • 5Sternbach H.The serotonin syndrome.Am J Psychiatry,1991,148:705-713.
  • 6Dunkley EJ,Isbister GK,Sibbritt D,et al.The Hunter Serotonin Toxicity Criteria:simple and accurate diagnostic decision rules for serotonin toxicity.QJM,2003,96:635-642.
  • 7Saper CB.Brain stem modulation of sensation,movement,and consciousness.In:Kandel ER,Schwartz JH,Jessell TM,eds.Principles of neural science.4th ed.New York:McGraw-Hill,2001.896.
  • 8Isbister GK,Buckley NA.The pathophysiology of serotonin toxicity in animals and humans:implications for diagnosis and treatment.Clin Neuropharmacol,2005,28:205-214.
  • 9Hu Z,Yang X,Ho PC,et al.Herb-drug interactions:a literature review.Drugs,2005,65:1239-1282.
  • 10Isbister GK,Bowe SJ,Dawson A,et al.Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.J Toxicol Clin Toxicol,2004,42:277-285.

共引文献27

同被引文献59

引证文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部